I was just clarifying the process outlined at the AGM. The patient will always get scanned first by the standard of care and then the EMV scan will be secondary. Standard of care / approved and proven technology will always be used as a priority over a scan involved in a trial. The patient care comes first.
EMvision Research Notes, page-1914
-
- There are more pages in this discussion • 657 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.99 |
Change
-0.010(0.50%) |
Mkt cap ! $170.8M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.06 | $1.99 | $120.4K | 60.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 255 | $1.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.00 | 1000 | 1 |
View Market Depth
| Last trade - 15.55pm 23/07/2024 (20 minute delay) ? |
| EMV (ASX) Chart |